Agilon Health, Inc. (NYSE:AGL) Receives $2.18 Average Target Price from Brokerages

Agilon Health, Inc. (NYSE:AGL) has been given an average recommendation of “Hold” by the fifteen brokerages that are currently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, ten have given a hold recommendation and three have issued a buy recommendation on the company. The average 12-month price target among analysts that have covered the stock in the last year is $2.1750.

A number of research analysts have weighed in on the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Agilon Health in a report on Wednesday, January 21st. BTIG Research restated a “neutral” rating on shares of Agilon Health in a research report on Friday, December 12th. Wells Fargo & Company upped their price target on Agilon Health from $1.00 to $1.50 and gave the stock an “overweight” rating in a research note on Friday, February 27th. Citigroup decreased their price objective on Agilon Health from $0.85 to $0.75 and set a “neutral” rating for the company in a report on Tuesday, March 3rd. Finally, Royal Bank Of Canada raised Agilon Health from a “hold” rating to a “moderate buy” rating in a research report on Wednesday, December 3rd.

Agilon Health Price Performance

AGL stock opened at $0.43 on Friday. The stock has a market capitalization of $177.15 million, a price-to-earnings ratio of -0.45 and a beta of 0.11. The firm’s 50-day moving average price is $0.67 and its two-hundred day moving average price is $0.78. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. Agilon Health has a 12-month low of $0.34 and a 12-month high of $6.08.

Agilon Health shares are set to reverse split before the market opens on Tuesday, March 31st. The 1-25 reverse split was announced on Wednesday, March 18th. The number of shares owned by shareholders will be adjusted after the market closes on Monday, March 30th.

Agilon Health (NYSE:AGL) last released its quarterly earnings data on Wednesday, February 25th. The company reported ($0.46) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.19). The business had revenue of $1.57 billion during the quarter, compared to analysts’ expectations of $1.46 billion. Agilon Health had a negative return on equity of 120.82% and a negative net margin of 6.60%. As a group, equities analysts predict that Agilon Health will post -0.59 earnings per share for the current year.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the business. Goldman Sachs Group Inc. increased its holdings in shares of Agilon Health by 196.2% during the fourth quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company’s stock valued at $13,812,000 after acquiring an additional 13,283,930 shares in the last quarter. AQR Capital Management LLC raised its position in shares of Agilon Health by 1,346.6% in the 4th quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company’s stock worth $7,033,000 after purchasing an additional 9,505,837 shares during the last quarter. CenterBook Partners LP boosted its stake in Agilon Health by 492.4% in the 3rd quarter. CenterBook Partners LP now owns 11,428,027 shares of the company’s stock worth $11,771,000 after purchasing an additional 9,499,012 shares in the last quarter. North Peak Capital Management LLC grew its position in Agilon Health by 10.8% during the 4th quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock valued at $26,267,000 after purchasing an additional 3,715,460 shares during the last quarter. Finally, Voleon Capital Management LP grew its position in Agilon Health by 5,519.2% during the 3rd quarter. Voleon Capital Management LP now owns 2,741,039 shares of the company’s stock valued at $2,823,000 after purchasing an additional 2,692,259 shares during the last quarter.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.